Literature DB >> 28815071

Gastro-esophageal junction cancers: what is the best minimally invasive approach?

Egle Jezerskyte1, Mark I van Berge Henegouwen1, Miguel A Cuesta2, Suzanne S Gisbertz1.   

Abstract

The short-term advantages of minimally invasive esophagectomy (MIE) in terms of less morbidity and better quality of life (QoL) in comparison with open esophagectomy (OE) became visible in the last few years. There are two main MIE approaches: a transthoracic esophagectomy (TTE) (either accompanied by an intrathoracic or cervical anastomosis) or a transhiatal esophagectomy (THE) (accompanied by a cervical anastomosis). Additionally, minimally invasive gastrectomy is increasingly gaining popularity over open gastrectomy. Controversy still exists about what approach is the best for esophagogastric junction tumors (EGJ) and the choice of the approach is currently based on the surgeons' discretion. In this study, we describe the definition, staging and classification, indications for each minimally invasive approach for EGJ tumors, the surgical technique, current developments and problems regarding surgical treatment for patients with cancer of the EGJ.

Entities:  

Keywords:  Ivor Lewis; Minimally invasive surgery; esophagectomy; esophagogasric anastomosis; esophagogastric tumors; junction tumors

Year:  2017        PMID: 28815071      PMCID: PMC5538974          DOI: 10.21037/jtd.2017.06.56

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  33 in total

Review 1.  [Robot-assisted minimally invasive esophagectomy. German version].

Authors:  R van Hillegersberg; M F J Seesing; H J F Brenkman; J P Ruurda
Journal:  Chirurg       Date:  2016-08       Impact factor: 0.955

2.  Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial.

Authors:  Surya S A Y Biere; Mark I van Berge Henegouwen; Kirsten W Maas; Luigi Bonavina; Camiel Rosman; Josep Roig Garcia; Suzanne S Gisbertz; Jean H G Klinkenbijl; Markus W Hollmann; Elly S M de Lange; H Jaap Bonjer; Donald L van der Peet; Miguel A Cuesta
Journal:  Lancet       Date:  2012-05-01       Impact factor: 79.321

3.  Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival.

Authors:  A Koen Talsma; Joel Shapiro; Caspar W N Looman; Pieter van Hagen; Ewout W Steyerberg; Ate van der Gaast; Mark I van Berge Henegouwen; Bas P L Wijnhoven; J Jan B van Lanschot; Maarten C C M Hulshof; Hanneke W M van Laarhoven; Grard A P Nieuwenhuijzen; Geke A P Hospers; Johannes J Bonenkamp; Miguel A Cuesta; Reinoud J B Blaisse; Olivier R C Busch; Fiebo J W ten Kate; Geert-Jan Creemers; Cornelis J A Punt; John T M Plukker; Henk M W Verheul; Herman van Dekken; Maurice J C van der Sangen; Tom Rozema; Katharina Biermann; Jannet C Beukema; Anna H M Piet; Caroline M van Rij; Janny G Reinders; Hugo W Tilanus
Journal:  Ann Surg       Date:  2014-11       Impact factor: 12.969

4.  Global incidence of oesophageal cancer by histological subtype in 2012.

Authors:  Melina Arnold; Isabelle Soerjomataram; Jacques Ferlay; David Forman
Journal:  Gut       Date:  2014-10-15       Impact factor: 23.059

5.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

Authors:  J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray
Journal:  Eur J Cancer       Date:  2013-02-26       Impact factor: 9.162

6.  Surgical treatment of adenocarcinomas of the gastro-esophageal junction.

Authors:  K Parry; L Haverkamp; R C G Bruijnen; P D Siersema; J P Ruurda; R van Hillegersberg
Journal:  Ann Surg Oncol       Date:  2014-09-05       Impact factor: 5.344

7.  Centralization of esophageal cancer surgery: does it improve clinical outcome?

Authors:  M W J M Wouters; H E Karim-Kos; S le Cessie; B P L Wijnhoven; L P S Stassen; W H Steup; H W Tilanus; R A E M Tollenaar
Journal:  Ann Surg Oncol       Date:  2009-04-16       Impact factor: 5.344

8.  Quality of Life and Late Complications After Minimally Invasive Compared to Open Esophagectomy: Results of a Randomized Trial.

Authors:  K W Maas; M A Cuesta; M I van Berge Henegouwen; J Roig; L Bonavina; C Rosman; S S Gisbertz; S S A Y Biere; D L van der Peet; J H Klinkenbijl; M W Hollmann; E S de Lange; H J Bonjer
Journal:  World J Surg       Date:  2015-08       Impact factor: 3.352

9.  Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma.

Authors:  M C J Anderegg; P C van der Sluis; J P Ruurda; S S Gisbertz; M C C M Hulshof; M van Vulpen; N Haj Mohammed; H W M van Laarhoven; M J Wiezer; M Los; M I van Berge Henegouwen; R van Hillegersberg
Journal:  Ann Surg Oncol       Date:  2017-04-19       Impact factor: 5.344

10.  Techniques and short-term outcomes for total minimally invasive Ivor Lewis esophageal resection in distal esophageal and gastroesophageal junction cancers: pooled data from six European centers.

Authors:  Jennifer Straatman; Nicole van der Wielen; Grard A P Nieuwenhuijzen; Camiel Rosman; Josep Roig; Joris J G Scheepers; Miguel A Cuesta; Misha D P Luyer; Mark I van Berge Henegouwen; Frans van Workum; Suzanne S Gisbertz; Donald L van der Peet
Journal:  Surg Endosc       Date:  2016-04-29       Impact factor: 4.584

View more
  1 in total

1.  Successful robotic proximal gastrectomy with side overlap esophagogastrostomy following preoperative chemotherapy: A case report.

Authors:  Kazuaki Tanabe; Yoshihiko Saeki; Hiroshi Ohta; Hideki Ohdan
Journal:  Int J Surg Case Rep       Date:  2022-04-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.